Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
Aldactone 25 mg Film-coated Tablets.
| Pharmaceutical Form |
|---|
|
Film-coated Tablets. Buff film-coated tablets with “SEARLE 39” engraved on one side. |
Each tablet contains 25 mg spironolactone.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Spironolactone |
Spironolactone, as a competitive aldosterone antagonist, increases sodium excretion whilst reducing potassium loss at the distal renal tubule. It has a gradual and prolonged action. |
| List of Excipients |
|---|
|
Calcium sulfate dihydrate |
Amber glass or plastic bottles containing 100 or 500 tablets.
HDPE containers of 50 or 1,000 tablets.
PVC/foil blister packs containing 100 or 500 tablets and PVC/foil blister calendar pack of 28 tablets.
Not all pack sizes may be marketed.
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
PL 00057/0928
Date of change of ownership: 16 September 2014
Date of latest renewal: 10 February 2002
| Drug | Countries | |
|---|---|---|
| ALDACTONE | Australia, Brazil, Canada, Germany, Ecuador, Spain, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Malta, Mexico, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
